Showing results (131-140 of 182) with videos related to
Sort By:
Pageof 19
Vaccines|September 23, 2022
Intranasal Treatment of Ferrets with Inert Bacterial Spores Reduces Disease Caused by a Challenging H7N9 Avian Influenza VirusJoe James, Stephanie M Meyer, Huynh A Hong, et al.Clinical Breast Cancer|February 12, 2014
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancerKomal Jhaveri, Sarat Chandarlapaty, Diana Lake, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342Eric P Winer, Donald A Berry, Susan Woolf, et al.Cancer Prevention Research (Philadelphia, Pa.)|July 26, 2012
Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancerKatherine D Crew, Powel Brown, Heather Greenlee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002Eric P Winer, Clifford Hudis, Harold J Burstein, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physiciansJeanne S Mandelblatt, Vanessa B Sheppard, Arti Hurria, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2014
Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901Vanessa B Sheppard, Leigh Anne Faul, George Luta, et al.Cancers|October 27, 2022
Event-Free Survival in Patients with Early HER2-Positive Breast Cancer with a Pathological Complete Response after HER2-Targeted Therapy: A Pooled AnalysisSandra M Swain, Harrison Macharia, Javier Cortes, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Cytochrome P450 Oxidoreductase (POR) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103Fei Shen, Guanglong Jiang, Santosh Philips, et al.The New England Journal of Medicine|June 7, 2016
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 YearsPaul E Goss, James N Ingle, Kathleen I Pritchard, et al.Pageof 19